In 2024, Joaquin Duato earned $13.03M in total compensation at Johnson & Johnson, including $1.60M salary, $3.22M bonus and $7.13M in stock. Most recently acquired 31,319 shares in Feb 2023. Currently holds stock worth $55.88M. 3+ years at the helm of Johnson & Johnson.
Compensation History
Annual executive compensation data for Joaquin Duato, including salary, bonuses, and stock awards.
Year
2024
Total Compensation
$13.03M
Salary
$1.60M
Bonus
$3.22M
Other
$1.08M
Salary
$1.60MBoard Justification
We design our executive compensation program to attract, retain and motivate global business leaders who can achieve financial and strategic objectives and build long-term shareholder value.
Bonus
$3.22MBoard Justification
The Board believes the Company largely met or exceeded its combined financial and strategic goals in 2024 under Mr. Duato's leadership. The Board recognized Mr. Duato's performance by awarding him an annual performance bonus at 115.0% of target.
Other Compensation
$1.08MBoard Justification
The amounts reported in column E represent the aggregate dollar amount for each non-employee Director for charitable matching contributions.
Restricted Stock
Board Justification
The values vary based upon the termination circumstances as described under Long-term incentive vesting and treatment upon termination on page 79.
Performance Metrics
The Board assessed Mr. Duato’s 2024 performance primarily upon its evaluation of the Company’s performance. The Company’s 2024 performance is summarized under 2024 Annual incentive goals and performance on pages 64 through 66.
Joaquin Duato
CEO of Johnson & Johnson
Education
MBA from ESADE in Barcelona, Spain; Master of International Management from Thunderbird School of Global Management at Arizona State University
Field of Expertise
Business & Management
Sector of Economy
Healthcare
Born
September 1, 1962 - 63 years ago
CEO of Johnson & Johnson for
3 years 11 months (Jan 2022 - Present)
Previous Experience
Joined Johnson & Johnson in 1989, held various positions including President of Ortho Biotech, LP, Company Group Chairman for Ortho Clinical Diagnostics, and Worldwide Chair of the pharmaceuticals business.
Other Johnson & Johnson CEOs
Holdings
Track Joaquin Duato's stock holdings and portfolio value over time.
Total Stock Sold
$11.98M
$11.98M
90,000 JNJ shares
What if they kept their stock?
If Joaquin Duato didn't sell their stock, today they would have:
Extra JNJ90,000 shares worth $18.22M.
This is 52.12% and $6.24M more than what they got when they sold the stock.
Insider Trading
Joaquin Duato's recent stock transactions, purchases, and sales filed with the SEC.
31,319 shares
JNJ
Feb 13, 2023
Received
2,332 shares
HES
Mar 6, 2021
Received
$25.01K
HES at $49.72/share
Mar 6, 2020
Purchase
3,557 shares
HES
Mar 6, 2020
Received
3,710 shares
JNJ
Feb 8, 2019
Received
$5.77M
JNJ at $144.36/share
Nov 7, 2018
Sale
8,831 shares
JNJ
Feb 12, 2018
Received
$6.18M
JNJ at $123.62/share
Mar 3, 2017
Sale
8,897 shares
JNJ
Feb 13, 2017
Received
Rivals
Compare Joaquin Duato with competitor CEOs and industry peers.
Darren W. Woods
CEO of Exxon Mobil
2024 Compensation
Stock
$10.69M
Salary
$1.97M
Bonus
$4.55M
Other
$396.89K
Total Holdings
$421.98M
Albert Bourla
CEO of Pfizer
2024 Compensation
Stock
$0.00
Salary
$1.80M
Bonus
$7.02M
Other
$996.06K
Total Holdings
$18.14M
Robert M. Davis
CEO of Merck & Co.
2024 Compensation
Stock
$18.10M
Salary
$1.62M
Bonus
$0.00
Other
$561.11K
Total Holdings
$43.45M
Stanley C. Erck
CEO of Novavax
2023 Compensation
Stock
$129.78K
Salary
$50.90K
Bonus
$0.00
Other
$3.83M
Total Holdings
$4.60M
Stéphane Bancel
CEO of Moderna
2023 Compensation
Stock
$0.00
Salary
$1.58M
Bonus
$1.91M
Other
$1.07M
Total Holdings
$335.71M